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Abstract
Background: Oral candidiasis is a common fungal disease mainly caused by Candida albicans. The aim of this
study was to investigate the effects of A-type cranberry proanthocyanidins (AC-PACs) on pathogenic properties of
C. albicans as well as on the inflammatory response of oral epithelial cells induced by this oral pathogen.
Methods: Microplate dilution assays were performed to determine the effect of AC-PACs on C. albicans growth as
well as biofilm formation stained with crystal violet. Adhesion of FITC-labeled C. albicans to oral epithelial cells and
to acrylic resin disks was monitored by fluorometry. The effects of AC-PACs on C. albicans-induced cytokine
secretion, nuclear factor-kappa B (NF-B) p65 activation and kinase phosphorylation in oral epithelial cells were
determined by immunological assays.
Results: Although AC-PACs did not affect growth of C. albicans, it prevented biofilm formation and reduced
adherence of C. albicans to oral epithelial cells and saliva-coated acrylic resin discs. In addition, AC-PACs
significantly decreased the secretion of IL-8 and IL-6 by oral epithelial cells stimulated with C. albicans. This anti-
inflammatory effect was associated with reduced activation of NF-B p65 and phosphorylation of specific signal
intracellular kinases.
Conclusion: AC-PACs by affecting the adherence properties of C. albicans and attenuating the inflammatory
response induced by this pathogen represent potential novel therapeutic agents for the prevention/treatment of
oral candidiasis.
Background
Candida albicans is a commensal microorganism that
colonizes the oral cavity of a large proportion of humans.
Although in most cases this yeast does not cause any
harmful effects, an overgrowth of C. albicans may result in
candidiasis. Several factors that induce changes in the oral
environment can predispose individuals to oral candidiasis
and include: antibiotics and corticosteroid use, xerostomia,
diabetes mellitus, nutritional deficiencies, and immuno-
suppressive diseases and therapy [1]. More specifically,
denture stomatitis is a common form of candidiasis affect-
ing denture wearers and characterized by an inflammation
of the oral mucosal areas induced by C. albicans [2]. Sev-
eral virulence properties of C. albicans, which contribute
to the development of oral candidiasis have been identi-
fied. They include i) adhesins that allow these organisms
to adhere to oral epithelial cells with subsequent invasion
[3], ii) the capacity to form biofilm on both oral mucosa
and denture devices [4,5], and iii) the ability to switch
from yeast form to mycelium form [6].
I nm u c o s a li n f e c t i o n ss u c ha so r a lc a n d i d i a s i s ,t h ei n n a t e
immunity is very important and involves neutrophils,
macrophages, natural killer cells, dendritic cells, and non-
hematopoietic cells, such as mucosal epithelial cells. There
are two main outcomes from the interaction of innate
immune cells with C. albicans: i) a direct anti-fungal activ-
ity, and ii) a regulatory activity that promotes the chemo-
taxis, proliferation, and terminal differentiation of cells
from both innate and adaptive immune systems, through
the synthesis of cytokines. Although pro-inflammatory
cytokines might serve to limit the progression of infection,
they may also be involved in immunopathology and tissue
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metalloproteinases (MMPs) [7-10] or by provoking an
uncontrollable leukocyte mobilization [11].
Despite the availability of a wide range of antifungal
agents for the treatment of oral candidiasis, failure of ther-
apy is observed frequently [12]. As a matter of fact, the
ability of C. albicans to form biofilms on epithelial surfaces
and prosthetic devices reduces its susceptibility to antifun-
gal agents [13,14]. Cranberry extracts and purified com-
pounds have been suggested as potential therapeutic
agents in various areas of health, including cancer, cardio-
vascular diseases and infectious diseases [15-17]. More
specifically, the proanthocyanidins isolated from cranberry
fruits possessed unusual structures with A-type linkages
containing a second ether linkage between an A-ring of
the lower unit and the C-2 ring of the upper unit (O7 C2),
a characteristic that has been associated with their anti-
adherence property [18]. In this study we investigated the
ability of A-type cranberry proanthocyanidins (AC-PACs)
to inhibit growth, adherence properties and biofilm forma-
tion of C. albicans, as well as to reduce the inflammatory
response of oral epithelial cells induced by C. albicans.
Methods
Isolation of A-type cranberry proanthocyanidins
Cranberry proanthocyanidins were isolated from cranberry
fruit (Vaccinium macrocarpon Ait.) using solid-phase chro-
matography as described previously [19]. Briefly, cranberry
fruit was homogenized with 70% aqueous acetone and fil-
tered, and the pulp was discarded. The collected extract
was concentrated under reduced pressure to remove acet-
one. The cranberry extract was suspended in water, applied
to a preconditioned C18 solid-phase chromatography col-
umn, and washed with water to remove sugars, followed by
acidified aqueous methanol to remove acids. The fats and
waxes retained on the C18 sorbent were discarded. The
polyphenolic fraction containing anthocyanins, flavonol
glycosides, and proanthocyanidins (confirmed using
reverse-phase high-pressure liquid chromatography
[HPLC] with diode array detection) was eluted with 100%
methanol and dried under reduced pressure. This fraction
was suspended in 50% ethanol (EtOH) and applied to a
preconditioned Sephadex LH-20 column which was
washed with 50% EtOH to remove low-molecular-weight
anthocyanins and flavonol glycosides. Proanthocyanidins
adsorbed to the LH-20 were eluted from the column with
70% aqueous acetone and monitored using diode array
detection at 280 nm. The absence of absorption at 360 nm
and 450 nm confirmed that anthocyanins and flavonol gly-
cosides were removed. Acetone was removed under
reduced pressure and the resulting purified proanthocyani-
din extract freeze-dried. The presence of A-type bonds and
the concentration of proanthocyanidins in the preparation
were evaluated using various analytical methods including
13C nuclear magnetic resonance (NMR), electrospray mass
spectrometry, matrix-assisted laser desorption ionization-
time-of-flight mass spectrometry, and acid-catalyzed degra-
dation with phloroglucinol [18,20].
C. albicans and culture conditions
C. albicans ATCC 28366 (oral origin) was cultivated in
yeast nitrogen base (YNB) broth (BBL Microbiology Sys-
tems, Cockeysville, MD) + 0.5% glucose pH 7.0 under
aerobic conditions at 37°C for 24 h. Cells were collected
by centrifugation, washed twice with sterile physiologic
saline (0.85% NaCl), concentrated ten times in saline and
kept at 4°C until further use (for less than 6 days). Cells
were diluted in YNB + 0.5% glucose pH 7.0 to the appro-
priate concentration just before to perform experiments.
Effect on C. albicans growth
Serial 1:2 dilutions of AC-PACs in YNB broth + 0.5%
glucose (from 100 to 6.25 μg/ml) were prepared in a flat-
bottomed 96-well microplate (Sarstedt, Newton, NC).
Control wells with no AC-PACs were also prepared.
Then, an equal volume (100 μl) of the yeast suspension
(5 × 10
4 cells /ml as determined with a Petroff-Hausser
counting chamber) was added. After a 24-h incubation at
37°C under aerobic conditions, growth was monitored by
recording the optical density at 660 nm. Assays were per-
formed in triplicate and repeated three times.
Effect on C. albicans biofilm formation
Two hundred and fifty μl of the yeast suspension (10
7
cells/ml) were added to wells of a 24-well tissue culture
plate (Sarstedt) containing 250 μl of 1:2 serial dilutions
(from 100 to 6.25 μg/ml) of AC-PACs in YNB broth +
0.5% glucose pH 7.0. Control wells with no AC-PACs
were also inoculated. After incubation for 48 h at 37°C
under aerobic conditions, spent media and free-floating
microorganisms were removed by aspiration and the
wells were washed twice with 10 mM phosphate-buffered
saline (PBS, pH 7.4), prior to quantify biofilm by crystal
violet staining, as previously reported [21]. Briefly, 0.02%
crystal violet was added into wells for 45 min, which
were then washed twice with PBS to remove unbound
dye. After adding 250 μl of 95% ethanol into each well,
the plate was shaken for 10 min to release the dye and
the biofilm was quantified by measuring the absorbance
at 550 nm (A550). Biofilm images of unstained prepara-
tions were acquired in phase-contrast mode using an
Olympus FSX100 fluorescence microscope (Olympus,
Tokyo, Japan). Assays were done in triplicate and three
independent experiments were performed.
Effect on C. albicans biofilm detachment
C. albicans biofilms were formed during 48 h as described
above. After removing spent media and free-floating
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were incubated with AC-PACs at concentrations ranging
from 100 to 6.25 μg/ml (in YNB broth + 0.5% glucose) for
30 min and 120 min at 37°C. Control biofilms were incu-
bated with YNB broth + 0.5% glucose alone. After incuba-
tion, biofilms were washed with PBS and quantified by
crystal violet staining as described above. Assays were
done in triplicate and three independent experiments were
performed.
Effect on adherence of C. albicans to oral epithelial cells
Human oral epithelial cells GMSM-K [22], kindly provided
by Dr. Valerie Murrah (University of North Carolina, Cha-
pel Hill, NC, USA), were cultured in Dulbecco’s modified
Eagle’s medium (DMEM) supplemented with 10% heat-
inactivated fetal bovine serum (FBS) and 100 μg/ml of
penicillin G-streptomycin, and incubated at 37°C in an
atmosphere of 5% CO2. Epithelial cells were seeded at a
concentration of 4 × 10
5 cells/ml in above conditions in
sterile 96-well clear bottom black microplates (Greiner Bio
One, Frickenhausen, Germany) and incubated until con-
fluence. Then, the wells were washed with DMEM-1%
heat-inactivated FBS, blocked with 1% bovine serum albu-
min (BSA) to prevent non specific fungal attachment, and
treated with AC-PACs diluted in DMEM-1% heat-inacti-
vated FBS medium at concentrations ranging from 100 to
6.25 μg/ml for 1 h in a 5% CO2 atmosphere at 37°C. Con-
trol wells not treated with AC-PACs were also prepared.
In parallel, cells from an overnight culture of C. albicans
were suspended at 10
9 cells/ml in carbonate buffer (0.15
MN a C l / 0 . 1MN a 2CO3, pH 9.0), and incubated for 1 h
with continuous shaking with 0.1 mg/ml fluorescein iso-
thiocyanate isomer I (FITC; Sigma-Aldrich Canada, Oak-
ville, Ontario, Canada). C. albicans were then washed
three times with PBS containing 0.05% Tween 20 and
resuspended in PBS. FITC-labeled C. albicans were
applied at a multiplicity of infection (MOI) of 15 (15 C.
albicans per epithelial cell) to AC-PACs pre-treated or
control epithelial cells and incubated for 30 min at 37°C.
All incubation and washing steps were carried out in the
dark. Following incubation, unbound C. albicans were
aspirated and wells were washed three times with PBS.
Adhered C. albicans were determined by monitoring the
fluorescence using a Synergy 2 Multi-Mode Microplate
Reader (BioTek Instruments, Winooski, VT, USA). The
excitation and emission wavelengths were set at 488 and
522 nm, respectively. Image processing was performed
using an Olympus FSX100 fluorescence microscope
(Olympus). Images of adhered FITC-labeled C. albicans
were observed at excitation and emission wavelengths of
488 and 522 nm, respectively, as well as in phase-contrast
mode. The assays were performed in triplicate and
repeated three times.
Effect on adherence of C. albicans to acrylic resin disks
Acrylic resin disks (6 mm-diameter and 0.3 mm-thickness)
were prepared as previously described [23], washed for
two h in saline, and then autoclaved in saline. Non-stimu-
lated saliva collected from five healthy volunteers was
pooled, filtrated and inactivated at 60°C for 30 min.
Acrylic resin disks were treated in the clarified heat-inacti-
vated saliva for 1 h at 37°C with constant shaking and
rinsed twice with PBS. Disks were incubated for 1 h at
37°C with intermittent shaking in the presence of equal
volumes (100 μl) of FITC-labeled C. albicans (10
7 cells/
ml) and AC-PACs at concentrations ranging from 100 to
6.25 μg/ml. Positive control consisted in disks incubated
with FITC-labeled C. albicans in PBS but without AC-
PACs. Unlabeled C. albicans incubated with discs served
as negative control. Following incubation, unbound
C. albicans were aspirated and disks were washed three
times with PBS. Fluorescence was measured using a
Synergy 2 Multi-Mode Microplate Reader. The excitation
and emission wavelengths were set at 488 and 522 nm,
respectively. Assays were performed in triplicate and
repeated three times.
Effect on cell surface hydrophobicity of C. albicans
This assay was performed according to the method
described by Ishida et al. [24] and using xylene as organic
solvent. Briefly, C. albicans at a concentration of 10
7 cells/
ml was incubated for 30 min at 37°C with AC-PACs at
100 μg/ml. Yeast cells were then washed with PBS, sus-
pended in the same buffer, and the optical density was
determined spectrophotometrically at a wavelength of 660
nm. The cells were mixed with xylene (2.5:1, v/v), shaken
for 2 min, and the tube was left for 20 min at room tem-
perature in order to obtain separation of the phases. The
turbidity of the aqueous phase was read at 660 nm. The
hydrophobicity index (HI) was calculated as HI = (ODcon-
trol -O D test) × 100/ODcontrol,w h e r eO D control = optical
density (660 nm) before xylene treatment and ODtest =
optical density (660 nm) after xylene treatment. Assays
were performed in triplicate and repeated three times.
Effect on the inflammatory response of oral epithelial
cells stimulated with C. albicans
Human oral epithelial cells GMSM-K were seeded in a
12-well plate (4 × 10
5 cells/well in 1 ml) and cultured
overnight in DMEM-10% heat-inactivated FBS medium
containing antibiotics at 37°C in a 5% CO2 atmosphere
to allow cell adhesion prior to the stimulation with
C. albicans. The epithelial cells were pre-treated with
increasing concentrations of AC-PACs (0, 25, 50, and
100 μg/ml) at 37°C in 5% CO2 for 1 h prior to stimulation
with C. albicans at MOIs of 3 and 15. After a 6-h incuba-
tion with C. albicans at 37°C in 5% CO2, cell-free
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used. Commercial enzyme-linked immunosorbent assay
(ELISA) kits (R & D Systems, Minneapolis, MN) were
used to quantify interleukin-6 (IL-6) and interleukin-8
(IL-8) concentrations in the cell-free supernatants
according to the manufacturer’s protocols. The absor-
bance at 450 nm was read using a microplate reader with
the wavelength correction set at 550 nm. The rated sensi-
tivities of the commercial ELISA kits were 9.3 pg/ml for
IL-6 and 31.2 pg/ml for IL-8. Assays were performed in
triplicate and repeated three times.
Analysis of NF-B p65 activation and kinase expression
To identify the mechanism of action of AC-PACs on
epithelial cells, their effect on different intracellular pro-
teins associated with inflammation was investigated. Oral
epithelial cells prepared as described above were incubated
with 50 μg/ml of AC-PACs for 30 min and then stimu-
lated with C. albicans at MOI of 15 for an additional
15 min at 37°C in a 5% CO2 atmosphere. Epithelial cells
stimulated or not with C. albicans in the absence of AC-
PACs served as controls. Whole-cell extracts were then
prepared using nuclear extract kits (Active Motif, Carls-
bad, CA) according to the manufacturer’sp r o t o c o la n d
adjusted to a protein concentration of 1 mg/ml. A sample
of cell extracts were shipped frozen to SearchLight Protein
Array Service (Pierce Biotechnology, Woburn, MA, USA)
for the assay of four phosphorylated protein kinases [AKT
(Ser473), AKT (Thr308), MEK1 (Ser217/Ser221), and
ERK1/2 (Thr202/Tyr204)] that are involved in inflamma-
tory signalling, by ELISA combined with piezoelectric
printing technology. Nuclear factor-B( N F - B) p65,
which is involved in secretion of proinflammatory media-
tors, was determined using a TransAm NF-B p65 kit
(Active Motif) according to the manufacturer’s protocol.
Assays were performed in triplicate and repeated three
times.
Effect of AC-PACs and C. albicans on viability of oral
epithelial cells
Epithelial cells were grown until confluence in DMEM-10%
heat-inactivated FBS medium supplemented with antibio-
tics at 37°C in a 5% CO2 atmosphere as described above.
Epithelial cells were seeded at a concentration of 4 × 10
5
cells/ml in 96-well microplates and cultured until conflu-
ence. Then, cells were treated with increasing concentra-
tions of AC-PACs (0, 6.25, 12.5, 25, 50 and 100 μg/ml),
with C. albicans at MOIs of 3 and 15, or with both AC-
PACs and C. albicans. After incubation for 24 h at 37°C in
a5 %C O 2 atmosphere, the cell viability was measured.
Viability of epithelial cells was determined using a 3-[4, 5-
dimethylthiazol-2-yl]-2, 5-diphenyltetrazolium (MTT) col-
orimetric assay (Roche Diagnostics, Mannheim, Germany)
according to the manufacturer’s protocol. This assay
measures mitochondrial dehydrogenase activity. Assays
were performed in quadruplicate and repeated three times.
Statistical analysis
The means ± standard deviations were calculated. The
statistical analysis was performed using Student t-test
with a level of significance of P < 0.05.
Results
The proanthocyanidin fraction purified from cranberry
was characterized by
13C NMR. As shown in Figure 1, the
proanthocyanidin molecules consist of epicatechin units
with degrees of polymerization (DP) mainly of 4 and 5
containing at least one A-type linkage, as previously
reported [18] (Figure 1). In order to investigate the capa-
city of AC-PACs to alter the virulence properties of
C. albicans, we tested their effect on growth, biofilm for-
mation and adhesion to oral epithelial cells and acrylic
resin disks. At all tested concentrations, AC-PACs did not
affect the growth of C. albicans.H o w e v e r ,t h eb i o f i l mo f
C. albicans formed after a 48 h-growth was significantly
inhibited by AC-PACs in a dose-dependent manner (Fig-
ure 2A). At the lowest concentration tested (6.25 μg/ml),
AC-PACs reduced biofilm formation by 23% ± 2.9%, while
at 100 μg/ml the inhibition reached 80% ± 4.8% compared
to untreated control (Figure 2A). The phase-contrast
images clearly showed a marked reduction of biofilm as
well as an alteration in its architecture when C. albicans
was grown in the presence of 25 μg/ml of AC-PACs (Fig-
ure 2B) as compared to control (Figure 2C). Thereafter,
the ability of AC-PACs to cause desorption of a preformed
(48 h) biofilm of C. albicans was evaluated. A 30-min
treatment of a newly formed biofilm with AC-PACs did
not affect significantly their biomass. However, increasing
the exposure time of C. albicans biofilms to AC-PACs at
120 min resulted in a significant detachment. AC-PACs at
a concentration ranging from 6.25 to 50 μg/ml were able
to reduce preformed biofilms by 25-30%, while the highest
concentration (100 μg/ml) caused a 50% ± 8% desorption
of C. albicans biofilm (Figure 3).
The effects of AC-PACs on the adherence properties of
C. albicans to oral epithelial cells and acrylic resin discs
were then tested. AC-PACs at 25 and 50 μg/ml reduced
C. albicans adherence to oral epithelial cells by 42% ±
11% and 90% ± 14%, respectively, while a complete inhi-
bition was observed at 100 μg/ml (Figure 4A). Fluores-
cence microscopy observations demonstrated a marked
r e d u c t i o ni nt h en u m b e ro fC. albicans attached to
epithelial cells in the presence of AC-PACs at 50 μg/ml
(Figure 4C, E) as compared to untreated control (Figure
4B, D). AC-PACs were also tested for its capacity to inhi-
bit C. albicans adhesion to acrylic resin discs, which
represent a model for denture materials. The inhibitory
effect was dose-dependent, and AC-PACs at the lowest
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adherence by 32%, while at the highest concentration
tested (100 μg / m l )a na l m o s tc o m p l e t ei n h i b i t i o no f
attachment of C. albicans to acrylic resin disks was
observed (Figure 5).
To get insight onto the mechanism by which AC-
PACs reduce C. albicans adhesion, experiments were
performed to investigate whether AC-PACs can modify
the cell surface hydrophobicity of C. albicans.A3 0 - m i n
incubation of C. albicans with AC-PACs at a concentra-
tion of 100 μg/ml decreased the hydrophobicity index
(HI) from 54% ± 4% to 7% ± 2%.
Lastly, we examined the capacity of AC-PACs to mod-
ulate the C. albicans-induced inflammatory response in
oral epithelial cells. In this purpose, epithelial cells were
pre-treated with AC-PACs prior to be stimulated with
C. albicans cells at MOI of 3 and 15. In the absence of
AC-PACs, C. albicans significantly and MOI-depen-
dently induced IL-6 and IL-8 secretion by epithelial cells
(Figure 6). AC-PACs decreased the secretion of both
cytokines in a dose-dependent manner when epithelial
cells were infected with C. albicans at either MOI of 3
or 15. More specifically, when epithelial cells were
exposed to C. albicans at an MOI of 3, AC-PACs at
concentrations of 25, 50, and 100 μg/ml reduced the
secretion of IL-6 by 36%, 76% and 89%, respectively, as
compared to control cells not treated with AC-PACs
(Figure 6A). In addition, IL-8 secretion was decreased
by 48%, 94% and 99%, respectively, as compared to con-
trol cells not treated with AC-PACs (Figure 6B). AC-
PACs also caused a similar inhibition of secretion of
both cytokines when C. albicans was used at an MOI of
15 (Figure 6). Neither C. albicans nor AC-PACs, alone
or in combination, reduced the viability of epithelial
Figure 1 Cranberry proanthocyanidins showing the presence of A-type linkages.
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Figure 2 Effect of AC-PACs on C. albicans biofilm formation.P a n e lA :C. albicans biofilms were quantified by staining with crystal violet.
Assays were done in triplicate and the means ± SD from three independent experiments were calculated. A value of 100% was assigned to the
biofilm formed in the absence of AC-PACs. *, significantly lower than the value for the untreated control (P < 0.05). Panels B and C: Phase
contrast microscopy of biofilms formed in the presence (B) or absence (C) of AC-PACs (25 μg/ml).
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Figure 3 Effect of AC-PACs on C. albicans biofilm desorption. Newly formed biofilms (48 h) of C. albicans biofilms were treated (30 and 120
min) with AC-PACs prior to determine biofilm biomass by staining with crystal violet. Assays were done in triplicate and the means ± SD from
three independent experiments were calculated. A value of 100% was assigned to the preformed biofilm unexposed to AC-PACs. *, significantly
lower than the value for the unexposed control (P < 0.05).
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shown).
The relative DNA-binding activity of nuclear transcrip-
tion factor NF-B p65 in epithelial cells infected with C.
albicans at MOI of 15 was increased up to 290% ± 13%
(Figure 7). Pretreating the cells with AC-PACs at 50 μg/
ml prior to stimulating them with C. albicans signifi-
cantly decreased the induced activity of NF-Bp 6 5 ,
down to the level of non-stimulated GMSM-K cells (Fig-
ure 7). Moreover, following a stimulation with C. albi-
cans (MOI of 15), the levels of phosphorylated kinases,
AKT (Ser473), AKT (Thr308), MEK1 (Ser217/Ser221)
and ERK1/2 (Thr202/Tyr204) were significantly
increased by 92%, 85%, 206% and 44%, respectively
(Table 1). However, when epithelial cells were pretreated
with AC-PACs at 50 μg/ml, the levels of phosphorylated
Figure 4 Effect of AC-PACs on adherence of C. albicans to oral epithelial cells. Panel A: FITC-labeled C. albicans adhered to epithelial cells
were quantified by measuring fluorescence in a microplate reader. Assays were done in triplicate and the means ± SD from three independent
experiments were calculated. A value of 100% was assigned to C. albicans adhered to epithelial cells not treated with AC-PACs. *, significantly
lower than the value for the untreated control (P < 0.05). Panels B to E: Image processing was performed using fluorescence microscope. Images
of C. albicans adhered to untreated or AC-PACs-treated epithelial cells in fluorescence mode (B and C, respectively) and in phase-contrast mode
(D and E, respectively).
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cantly reduced by 33% and 43% respectively, while the
elevated phosphorylation of ERK1/2 (Thr202/Tyr204)
returned to its basic non-stimulated state. The C. albi-
cans-mediated enhanced phosphorylation level of AKT
(Thr308) was not altered by AC-PACs (Table 1).
Discussion
Oral candidiasis is a common fungal disease for which
C. albicans is the major etiological agent. These infections
can be controlled by several means, the most effective
being a fungicidal approach. However, this approach has
numerous draw backs, the most serious one being the
emergence and spread of drug resistant strains [25]. A
variety of virulence attributes associated to C. albicans are
involved in the infection process. For example, the ability
to adhere and to form biofilms on biomaterials [26] and
oral mucosa [27] allows C. albicans to accumulate in large
amounts. In the biofilm, C. albicans is protected from
antimicrobial agents and the host immune system. Agents
interfering with biofilm formation and adherence proper-
ties represent a novel approach to control C. albicans
infections. By affecting C. albicans virulence properties,
this may minimize the appearance of resistant strains. Pre-
vious studies have reported antibiofilm activities of several
agents against candidal biofilms [28,29].
Proanthocyanidins isolated from the American cranberry
(V. macrocarpon) are composed of oligomers containing at
least one A-type interflavan bond, although there are often
multiple A-type interflavan linkages at each degree of poly-
merization within the proanthocyanidin oligomeric series
[20]. Numerous studies have demonstrated antiadhesion
and antibiofilm properties of AC-PACs attributed to their
unique A-type bond chemical structure [30-34]. While
these activities of cranberry PACs have been directed
against bacteria including Gram positive [33,35] and Gram
negative [32,34], it is still unknown whether cranberry
proanthocyanidins are able to exert such properties on
eukaryotic fungi. Our study showed that the formation and
architecture of C. albicans biofilm were strongly affected
by AC-PACs. Moreover, AC-PACs were capable to detach
a newly formed biofilm of C. albicans, a phenomenon that
is likely to alter its biological functions. Importantly, AC-
PACs exerted their antibiofilm activities while having no
effect on fungal growth, which is in agreement with other
studies reporting no alteration in bacterial growth and via-
bility due to the presence of AC-PACs [30,34]. The use of
such agents that disengage microorganisms from the bio-
film without affecting their viability may prove advanta-
geous, as selective pressure and overgrowth of resistant
fungus would be avoided [36].
Our study also showed that AC-PACs inhibit C. albicans
adherence to oral epithelial cells in a dose-dependent
mode. The ability of AC-PACs to inhibit the adherence of
C. albicans to epithelial cells suggests that this cranberry
fraction may be of interest for the prevention of oral can-
didiasis. Indeed, adhesion to epithelial cells is a key event
in pathogenic lifestyles of C. albicans [37,38] and conse-
quently its prevention could minimize the fungal viru-
lence. C. albicans h a sb e e nr e c o g n i z e da st h ep r i m a r y
agent of denture-related stomatitis, an inflammatory pro-
cess affecting the oral mucosa of 30-60% of patients
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Figure 5 Effect of AC-PACs on adherence of C. albicans to acrylic resin disks. FITC-labeled C. albicans adhered to saliva-coated acrylic resin
disks were quantified by measuring fluorescence in a microplate reader. Assays were done in triplicate and the means ± SD from three
independent experiments were calculated. Data were performed as relative fluorescence units (RFU) obtained from the disks incubated with C.
albicans and AC-PACs, and compared to control disks incubated with C. albicans alone. *, significantly lower than the value for the control (P <
0.05).
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Page 8 of 12wearing removable dental prostheses [39,40]. AC-PACs
also significantly reduced C. albicans adherence to acrylic
resin discs that mimic denture material.
Hydrophobic interactions are generally considered to
play an important role in the adherence of C. albicans to
eukaryotic cells and also to certain inert surfaces, such as
p r o s t h e t i cd e v i c e s[ 4 1 ] .T h e r e f o r e ,a g e n t sa b l et om o d i f y
surface characteristics of C. albicans may alter their
adherence capacity, and subsequently prevent biofilm
formation and subsequently invasion of host cells. In the
present study, AC-PACs markedly modified C. albicans
cell surface from being highly hydrophobic to hydrophi-
lic. This is in agreement with Ishida et al. [24], who
reported that tannins isolated from Stryphnodendron
adstringens decrease adherence of C. albicans to mam-
malian cells and to glass surfaces by lowering the fungi
cell surface hydrophobicity [24]. Thus, we propose that
the mechanism of antiadhesion and antibiofilm action of
AC-PACs may be at least in part attributed to a modifica-
tion of C. albicans cell surface. Previous reports docu-
mented a strong correlation between inhibition of
bacterial biofilm formation by various cranberry constitu-
ents and reduction of hydrophobicity of bacterial mem-
brane [42,43]. Cranberry PACs have been shown to alter
specifically and non-specifically bacterial surface macro-
molecules (fimbriae, LPS) [44]. Interestingly, exposure of
bacteria to cranberry juice for even a short time period
produced important changes in surface composition [45].
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Figure 6 Effect of AC-PACs on IL-6 and IL-8 secretion by C. albicans (MOI of 3 or 15)-stimulated oral epithelial cells. IL-6 (Panel A) and
IL-8 (Panel B) concentrations in the cell-free supernatants were determined by ELISA. Assays were run in triplicate, and the means ± SD from
three independent assays were calculated. *, significantly higher than the value for the unstimulated (C. albicans) control (P < 0.05); †,
significantly lower than the value for the untreated (AC-PACs) control (P < 0.05).
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Page 9 of 12Therefore, in order to evaluate the exact mode of antiad-
hesion activity, further experiments are required to deter-
mine the effect of AC-PACs on C. albicans cell wall-
associated adhesins such as ALS, Hwp1, Eap1, Iff, which
mediate fungal adherence [5,27,46].
The tissue homeostasis is regulated by several host
factors produced by immune and mucosal cells in a
healthy condition. Production of proinflammatory med-
iators by host cells in response to C. albicans plays a
critical role in the activation of immune cells and final
clearance of the organism [47]. Infections of oral epithe-
lial cell models with C. albicans identified a wide range
of pro-inflammatory mediators for which the secretion
was markedly increased [48]. In the present study, oral
epithelial cells infected with C. albicans (MOI = 15)
secreted a dramatically increased amount of the pro-
inflammatory cytokines, IL-6 (15-fold) and IL-8 (25-
fold). IL-6 and IL-8 are considered as the major pro-
inflammatory cytokine and chemokine for the recruit-
ment and activation of neutrophils and macrophages at
the site of infection [49,50]. However, due to the
protecting reaction of the host against fungal pathogens,
an accumulation of inflammatory mediators occur and
may lead to a chronic and persistent inflammation, and
ultimately to tissue destruction mediated by MMPs. In
regard to the resolution of the inflammatory process,
prevention of excessive activation of innate immunoef-
fectors or timely inactivation of their function is critical
for recovery from fungal infection. We showed a dose-
dependent inhibitory effect of AC-PACs on C. albicans-
induced secretion of IL-6 and IL-8 by epithelial cells.
These findings are in agreement with previous studies
reporting a strong anti-inflammatory activity of
proanthocyanidin-rich cranberry fractions towards dif-
ferent human cell lines infected with pathogens
[34,51-53].
The mechanisms involved in the proinflammatory med-
iator overexpression mediated by C. albicans in human
keratinocytes includes toll-like receptor-2 (TLR-2)-
induced activation of intracellular signal transduction
pathways including NF-B and various kinases [54]. In the
present study, we observed a significant activation of NF-
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Figure 7 Effect of AC-PACs on NF-Bp 6 5a c t i v a t i o nb yC. albicans (MOI of 15)-stimulated oral epithelial cells. The activation of NF-B
p65 in the cellular extract was determined by an ELISA-based assay. Assays were run in triplicate, and the means ± SD from three independent
assays were calculated. *, significantly higher than the value for the unstimulated (C. albicans) control (P < 0.05); †, significantly lower than the
value for the untreated (AC-PACs) control (P < 0.05).
Table 1 Effect of AC-PACs on the levels of phosphorylated protein kinases induced by C. albicans in oral epithelial
cells
Phosphorylated protein kinase Amounts of phosphorylated protein kinase (pg/ml)
No stimulation C. albicans stimulation (MOI = 15)
No pre-treatment AC-PAC pre-treatment
AKT (Ser 473) 614 ± 171 1184 ± 186* 782 ± 110*
AKT (Thr 308) 60 ± 17 111 ± 29* 113 ± 24
MEK1 (Ser 217/Ser 221) 2072 ± 383 6359 ± 255* 3596 ± 773
†
ERK1/2 (Thr 202/Tyr 204) 67 ± 2 97 ± 8* 41 ± 6
†
The data are the means ± SD of triplicate assays. *significantly higher compared to the unstimulated control (P < 0.05);
†significantly lower compared to the
untreated (AC-PACs) control (P < 0.05).
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Page 10 of 12B p65 as well as an increased phosphorylation of four
kinases, AKT (Ser473), AKT (Thr308), MEK 1(Ser217/
Ser221) and ERK 1/2 (Thr202/Thr204) in oral epithelial
cells infected with C. albicans. Interestingly, stimulation of
cytokine production in human monocytes by proteinases
of C. albicans was suggested to be regulated via AKT/NF-
B pathway, where AKT initiates translocation of NF-B
into the nucleus [55]. In addition, it has been shown that
inflammatory response of synovial fibroblasts induced by
C. albicans involves activation of ERK 1/2 and is asso-
ciated with NF-B activation [56]. The enhanced activa-
tion of extracellular signal-regulated kinases and
suppression of arachidonic acid release in C. albicans-
infected macrophages were reduced by MEK1 inhibitor,
suggesting that this kinase plays important role in candi-
diasis-associated inflammatory processes [57]. We pro-
vided evidence that AC-PACs inhibited, at least in part,
the C. albicans-induced secretion of IL-8 and IL-6 in oral
epithelial cells by their ability to inhibit the activation of
NF-B p65. This is in agreement with previous studies
showing that cranberry proanthocyanidins exert their anti-
inflammatory properties by modulating the NF-B path-
way [19,34,58]. Moreover, the present study showed that
AC-PACs inhibit the phosphorylation of major intracellu-
lar signaling proteins induced by C. albicans.T h u s ,i ti s
suggested that AC-PACs by interfering in signal transduc-
tion cascade may contribute to reduce the impact of host
inflammatory processes mediated by elevated production
of IL-6 and IL-8 occurring in oral candidiasis.
Conclusion
The present study demonstr a t e dt h a tA C - P A C s ,b y
affecting the virulence properties of C. albicans and,
parallely, attenuating the inflammation induced by this
pathogen, may have a beneficial effect as a novel thera-
peutic in prevention and treatment of oral candidiasis.
Clinical trials are required to demonstrate whether the
beneficial properties demonstrated under our assay con-
ditions may be observed in vivo.
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